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The patella is an uncommon location for cancerous occurrence and development. The majority of tumors of the
patella are benign, with a significant incidence of giant cell tumors and chondroblastoma. With the development
of modern diagnostic technologies, there appear however many other histological types which raise challenges
of diagnosis and treatment. In this article, we review the reported histological types of primary patellar tumors.
Specifically, epidemiology, symptomatology, imageology, histopathology, and treatment options for these
histological lesions will be discussed, respectively. As there is an increasing focus on the diagnosis and the
treatment of these lesions, the availability of the integrated information about primary patellar tumors becomes
more significant.
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Introduction
A low incidence of tumors is found in the patella with the
vast majority being giant cell tumor and chondroblastoma
[1]. Diagnosis and treatment for these histological types of
tumors are typically straight forward. However, some
other notable, yet uncommon histological types which
do not fall within these conventional patellar tumor
types can cause both diagnostic and treatment dilemmas.
The purpose of this manuscript is to discuss these current
reported types of patellar tumors, their clinical manifes-
tations, and appropriate treatment options. This list of
patellar benign tumors and malignancies is not meant to
be exhaustive. Many other, even rare factors that affect




Giant cell tumor (GCT) is the most common type of
the diagnosed patellar tumors (33% of all the patellar
tumors) [1].
Clinically, the patients with the patellar GCTs usually
complained about knee pains and/or swelling [2-5]. But
there may be no inducement to the initiation of relevant* Correspondence: dmu_makai@sina.com; luming_dmu@sina.com
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ical examination may show redness, local heat, swelling,
effusion, tenderness, lump, crepitus, and the decrease of
motional range [4-8].
The laboratory findings on some severe patients
showed an increase of serum alkaline phosphatase (AP)
[6,7] and erythrocyte sediment rate (ESR) [5,7].
Radiographs (Figure 1) revealed an osteolytic lesion of
the patella with destruction of the bone [2-5,7,8], and
sometimes, soap bubble appearance [7], sclerotic and
radiolucent lesion [6], fracture of the femur and the tibia
[3,6], and pathologic fracture [3] may also be found.
Magnetic resonance imaging (MRI) showed abnormal
extension and lesion of the patella, and there may be
some evidences of adjacent tissues and sclerotin
[2-4,8,9]. Additionally, chest radiography and bone scin-
tigraphy are necessary for GCT patients to determinate
the possible metastasis on the lung and other bones.
A needle biopsy or incisional biopsy of the patella is
recommended for the diagnosis. The histopathological
features of the patellar GCT, which mainly include
numerous giant cells, short spindle-shaped cells, bone tis-
sue calcification, and a few mitotic figures [2], should be
distinguished from aneurysmal bone cyst or chondroblas-
toma. The histological examination of the aggressive GCT
showed a compact stroma with nuclear atypia, frequent
mitotic figures, hyperchromatism, and the unevenly dis-
tributed giant cells [5,7].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Patellar giant cell tumor. (A, B) An enlargement of the cystic lesion in the patella and a bone translucency with peripheral rim change
can be seen at the lateral down part of the patella on radiographs. (C, D) CT indicates that there is a well-defined lytic lesion with the thin cortex
occupying two-thirds of the patella.
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locally bony lesion, a tumor considered as having low
recurrence rates using standard meticulous surgical tech-
nique according to Meyerding’s outline [10]. For small,
benign GCT (Enneking stage 2), intralesional curettage or
partial patellectomy with filling of the bone void and re-
construction of the extensor mechanism is the first choice
in treating GCT of the patella. But if the patellar GCT is
extensive or malignant (Enneking stage 2 to 3), patellect-
omy combined with adjuvant treatment and resection of
metastasis is recommended.
Chondroblastoma
Chondroblastoma (CB) can also be found in the patella
but at a very low occurrence rate (2%) [11]. It is the sec-
ondary common benign patellar tumor (16% of all the
patellar tumors) [1].
CB appears as lesions on the patella that caused pain
either with or without swelling [12-16]. The pain is ag-
gravated by physical exercises and alleviated when at
rest. Upon examination, CB patients had slight tender-
ness on the bad patella and some swelling with no ery-
thema or warmness. The movement gave a slight feeling
of pain when in extreme flexion. The patients who hadFigure 2 Chondroblastomas of the patella. (A) On plain radiographs, the le
cortex, sclerotic rim, and reactive bone. (B) Calcifications inside the lesion athe patellar CB with pathological fracture were found to
move in pain, which heavily affected the range of knee
motion [12,17].
Most of routine laboratory tests were within normal
ranges. The increased serum calcium and AP were only
found in the patients with patella fracture [12].
Plain radiographs (Figure 2) demonstrated a radio-
lucent lesion of the diseased patella with a well-defined
sclerotic margin, lobulated rims, and thinned cortices.
Patellar expansion and multicystic lesion of a ballooned
patella was indicated in the patients with CB and
aneurysmal bone cyst [16]. The fracture line appeared
on the radiograph of the patient with pathological frac-
ture [13,18]. Computed tomography (CT) scan revealed
an osteolytic lesion with septation, sclerotic margins, and
some calcifications in the patellar matrix [14-16]. MRI
for the patella showed a lobulated lesion, expanded pa-
tella, and fluid-fluid levels. Meanwhile, the margins of the
lesion were well defined [14-16]. Chest radiography was
no anomalous change.
Histological examination revealed sheets of proliferating
chondroblast with chondroid matrix and some multinu-
cleated giant cells in places admixed with focal areas of
coarse calcification [14-17]. Within the fibrous septumsion appears as geographic changes with lobulated margins, thinning
re seen on CT images.
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eral walled cystic zones full of blood and immature bone
formation, which are compatible with aneurysmal bone
cysts [15,16].
CB treatment included curettage, curettage with bur-
ring, and filling of the lesion cavity with bone graft and/
or bone cement [19]. For the patellar CB (Enneking
stage 2), curettage by the anterior longitudinal bone win-
dow was performed, followed by the filling of the cavity
with bone graft [14-16,18]. Partial patellectomy was used
for the CB patients with a pathological fracture [17]. In
addition, curettage followed by chemical adjuvant treat-
ment (Enneking stage 2) and excision (Enneking stage 1)
were reported in some cases [1,20]. For large-sized patel-
lar CBs with aneurysmal bone cyst, curetting with bone
grafts may be suitable; for large-sized or recurrent ones,
curettage and bone graft or patellectomy may be a better
option [16]. Postoperatively, immobilization of the affec-
ted limb and then static quadriceps exercises are necessary
for the patients to recover normal joint activities [16].
Osteoid osteoma
Although the patella is a rare site for osteoid osteoma
(OO) with only an incidence of 5% in all patellar tumors
[1], a few cases of such kind have been reported [21-24].
Long-term pain was the main complaint of the patellar
OO patients, which was presented throughout the day-
time and exacerbated at nighttime and after physical ex-
ercises; which was well localized at the patella and could
be relieved by analgesic drugs [21-24]. Swelling could
occur in the diseased knee as well [24]. There was no
previous trauma in most cases [21-23]. Physical examin-
ation revealed mild effusion, a tender point at the pa-
tella, and slight atrophy of the affected thigh; no redness
or local temperature rise. Range of motion was confined
due to pain [21-24]. Sometimes, clinical examination
could not be entirely completed due to severe pain [22].
Laboratory studies of reported cases were normal
[21-24].Figure 3 An intracortical osteoid osteoma of the patella. (A) On plain radio
(B) CT demonstrates the sclerosis surrounding the lesion.X-ray, CT, MRI, and bone scintigraphy were meaningful
to the determination of the patellar OO, for they showed a
well-defined lesion with nidus and mineralization in the
affected location of the patella [21-24] (Figure 3).
Several researchers suggested that the natural history
of osteoid osteoma be a process of spontaneous healing.
But studies indicated that it would take a long time to fully
resolve symptoms if the osteoid osteoma was not excised.
Non-steroidal anti-inflammatory drugs can reduce the time
of recovery period. OO was traditionally treated with ex-
cision of the nidus, so did patellar OO. Curettage nidus or
resection was performed to resolve symptoms (Enneking
stage 1) [21,23-25].
Aneurysmal bone cyst
Less than 1% aneurysmal bone cyst (ABC) of all the
known cases occurs in the patella [26]. Patellar ABC has
an incidence of 5% in all patellar tumors [1].
Patellar ABC patients frequently presented complaints
of pain in the anterior aspect of the affected knee and/or
swelling of the knee joint [26-30]. The clinical assess-
ment could not find any recent trauma or signs of
local inflammation. Palpation of the patella was pain-
ful and/or swelling compared to the healthy side [26-29].
Additionally, physical examination revealed full active and
passive ranges of motion of the affected knee [26-29].
Hemogram, c-reaction protein (CRP), and ESR were
completely within normal ranges [27].
Radiographs of the knee showed a ‘geographic oste-
olysis’ all over the affected patella, that is, cortical
thinning, smooth borders, and intact articular surface
[26-28]. Mild expansion and a multiloculated appear-
ance could also be observed [28]. CT scan showed a
fluid-filled multiseptate cavities without intralesional
calcifications in the patella suggesting an aneurysmal
cyst [27,28]. MRI showed a hyperintense lobulated
mass with fluid-filled cyst in the lesion of the patella
[26,29]. Doughnut-shaped patella was found on bone
scintigram [30].graphs, a clear lesion with small fuzzy periosteal reaction is observed.
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vealed empty bloody cavities or the presence of red
blood cells [27-29]. The cavities were separated by those
fibrous connective tissues composed of spindle cells, giant
multi-nucleated cells, some macrophages, masses of he-
mosiderin, and trabecular bone [27-29].
The best choice of ABC treatment is surgical sauceri-
zation and curettage with removal of the cyst lining
followed by bone grafting. Bone grafting or bone cement
following curettage with burring by a mid-line surgical
approach was employed to remove the lesion (Enneking
stage 2) [27-29]. Patellectomy was also performed in
some patients (Enneking stage 2) [1,20]. Reddy reported
an aggressive ABC case (Enneking stage 3) that received a
treatment consisting of curettage, chemical and thermal
cautery of the bed, and autogenous bone grafts [26].
Chondroma
Chondroma (CH), including both enchondroma (EC)
and juxtacortical chondroma (JC), is a rare lesion with
approximately 5% of incidence in patellar tumors [1].
Clinically, CH patients would state their ache, swelling,
and patellar mass [31,32]. One case had a history of
struck injury on the knee due to an automobile accident
[32]. After physical examination, such symptoms as mild
motion pain, mass, swelling, tenderness, heat of the pre-
patellar bursa, and extension were detected [31,32]. Pa-
tients usually had full active and passive range of motion
of the affected knee [32].
Routine laboratory studies and ESR were within nor-
mal ranges [31].
Radiographs of the knee revealed an oval lytic defect
within the patella in EC patients [31]. The mixed lesions
were showed on the edge of patella in JC patients. Well-
defined margins, normal cortex, and small calcifications
were presented, without any periosteal shell or reaction,
sclerotic rim, septation, fluid levels, pathologic fracture,
or joint involvement [33]. MRI of patellar JC patient
showed a hyperintense lesion in T2 sequences on the
edge of the patella [32].
Histologic examination revealed diseased tissue of hyaline
cartilage containing chondrocytes with small, condensed nu-
clei, which conformed to characteristic of chondroma [31].
Lammot [32] reported that patellectomy was perfor-
med in the patellar EC patient (Enneking stage 2), who
then recovered a stable knee without any further com-
plaints. Excisional surgery was used to resect the JC lesion
(Enneking stage 2), and the patient was finally capable of
full range of motion [31]. For the Enneking stage 1 CH,
excision and flap was used [1].
Osteochondroma
Osteochondroma (OC) in the patella is rare with an
approximate 2% incidence of patellar tumors [1].Clinically, patellar OC might cause the symptoms of
knee pain and mass [34,35]. Upon physical examination,
a hardened mass was found adhering to the patellar
bone plane, without any inflammation [34]. Limitation
of flexion was presented in the case of patellar intra-
articular OC [35].
Routine laboratory studies were within normal ranges
[35].
Upon radiographs, an irregular calcification neoforma-
tion that stretched from the edge of the affected patella
was detected [33-35]. Some lesions projected over the
pole of the patella, while others extended toward the
joints. Sometimes, the ‘bone bridge’ might be present
[35]. Both tomography and MRI were helpful to a me-
ticulous observation of the tumor and the patellofemoral
joint surface [34,35].
Anatomic pathologically, the lesion was a pale polypoid
tissue with the cartilage cap. Microscopically, the outer
layer was composed of connective tissues and the deep
layer of cartilage cells. Between these two layers, there were
normal spongy bone tissues [35]. The results accorded
with the diagnosed characteristics of osteochondroma.
Although the surgery to excise the tumor is not essential
to all OC cases, it is still a rational method for patients
who suffered from some OC symptoms and malignant
transformation. The OC surgery involved curettage, bur-
ring, bone grafting, and bone cementing. The simple re-
section was often found to inhibit the tumor growth and
to resolve the symptoms in Enneking stage 2 cases [34,35].
During the operation, the periosteum and perichondrium
covering the lesion were generally removed to reduce the
chances of a recurrence [36].
Osteoblastoma
Osteoblastoma (OB) in the patella is very rare (about 2%
of all patellar tumors) [1], and only a few cases of this
kind were reported [37-39].
The common symptoms of the patellar OB patients
are pain and swelling [38,39]. Local tenderness might be
observed during physical examination [38]. The motion
of the affected knee was usually of full range.
Radiograph of the patella revealed an osteolytic lesion
surrounded by a sclerotic rim without evidence of extra-
articular involvement [33,37,38]. OB might cause a pa-
tellar pathological fracture which could be detected by
radiograph [39]. Both tomography and CT scans con-
firmed a well-defined lesion of the patella with calcifica-
tions [37,38]. A solitary hot spot of the affected patella
could be revealed by bone scintigram [39].
The pathologic examination demonstrated that the
lesion comprised irregular trabeculae of immature woven
bone, lined by plump osteoblasts within a loosely tex-
tured fibrovascular stroma containing numerous giant
cells [37,38]. In the case with a pathological fracture,
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hemorrhage [37].
Generally, both conservative surgery and complete
resection (marginal or wide en bloc) are the options for
the OB treatment. Intralesional curettage can be effect-
ive but is associated with a high rate of recurrence. The
treatment method for local recurrences should be wide
en bloc resection [37]. Allogeneic bone grafting following
intralesional curettage was conducted to treat the patel-
lar OB in different cases (Enneking stage 1 to 2) [37,38].
Patellectomy could be the remedy for a failure after wide
curettage [39]. After the surgery, the patients were asymp-
tomatic, capable of full functioning of the knee, and
complete healing of the lesion without evidence of recur-
rence [37-39].
Osseous hemangioma
Patellar primary osseous hemangioma (OH) is very rare
with only an incidence of 2% in patellar tumors [1].
Clinically, complaints of the patellar OH patients could
include aching, swelling, and limitation of movements of
the knee [40].
Routine laboratory findings, such as blood count,
Mantoux test, ESR, blood calcium, blood phosphorus,
and AP, proved to be normal [40].
Upon radiographs of the knee joint, there is a multilo-
cular cystic lesion all over a part of patella with possible
surroundings of sharp margin, thinned cortex, and scler-
otic rim [33,40]. A secondary fracture could be found in
the radiographs [40]. CT could determine the radiogra-
phic results [40] (Figure 4).
Pathological findings showed that the loculated lesion
containing fluid and clotted blood was traversed by thin
bony septa. Existence of a fracture could be judged by vis-
ual inspection. Microscopically, the cyst consisted of large
and small spaces filled with endothelium and blood. Re-
active bone formation in the bony trabeculae running
across the lesion could be indicated, as well [40].Figure 4 Patellar hemangioma. (A) Radiographs show a lytic lesion with sh
with the radiographic results.Patellectomy was performed in the two patellar OH cases
(Enneking stage 1 to 2), and the treated patients were finally
capable of full movements of the knee joints [40].
Simple bone cyst
Simple bone cyst (SBC) comprises about 3% of all biop-
sied primary bone tumors and accounts for 4% of patel-
lar tumors [1].
The patellar SBC patients usually complained about
knee pain and swelling [41-43]. The pain could be related
to traumatic history and aggravated by motion and climb-
ing [41,42]. Upon physical examination, tenderness, swell-
ing, flexion deformity, and the result of a positive patellar
grinding test could be detected [41-43].
Radiographs showed a radiolucent lesion with well-
defined margins in the affected location of the patella
[41-44]. There might be a cortical destruction arising
from a fracture [42]. CT could determine the radiographic
results, indicating the elaborate changing of the cortex
and patellofemoral joint [41,44]. Bone scintigram was
normal [41].
Laboratory investigations did not reveal any abnormal
findings [41].
Macroscopically, the lesion included a cyst lined with
a thin membrane and a smooth inner surface, full of
clear or yellowish fluid [41,42]. Microscopically, the
histological findings about the simple cyst were consist-
ent with the diagnosis of SBC [44].
The patellar SBC lesions were eliminated by autogenous
grafting following curettage (Enneking stage 1) [41] or
patellectomy (Enneking stage 1 to 2) [42,43]. Restoration of
the extensor mechanism was performed after patellectomy
[43]. Postoperative cases were asymptomatic, capable of full
motion of the affected knee with no recurrence [41-43].
Other benign patellar tumors
Other benign patellar tumors that have been reported in-
clude lipoma, osteitis fibrosa cystica, ganglion, osteoma,arp margins, thinning cortex, and sclerotic rim. (B, C) CT results accord
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reports, more details cannot be obtained. Known informa-
tion thereof is shown in Table 1.
Malignant patellar tumor
Osteosarcoma
Osteosarcoma (OS) is the most common type of primary
malignant osseous tumor. It mainly affects the long bones
of the extremities but also affects other bones like pa-
tella. The patellar OS has an incidence of 6% in patellar
tumors [1].
The patellar OS patients complained about the in-
creasing anterior knee pain and swelling in the affected
knee [45-49]. Most of them did not have history of knee
injury [45-48], while some had a history of trauma or
radiation [6,49]. Symptoms of a few cases might dis-
appear after the conservative management [46]. Physical
examination could reveal tenderness, swelling, redness,
limited flexion, and muscle atrophy around the affected
thigh [45-48].
Plain radiographs (Figure 5) showed lytic lesion, osteo-
blastic lesion, shape changing, and cortical thinning/
breach in the patella [45-49]. OS mimicking GCT pre-
sented the multilocular lytic lesion [46]. Most of the
cases had no cortical wall destruction in the patellofe-
moral joint [45-47,50]. The telangiectatic OS cases dem-
onstrated a lytic lesion of the surrounding bone and
osteoid matrix in the soft tissues extended from the pa-
tella [48]. CT scans could demonstrate soft tissue exten-
sion and an intraosseous lytic lesion with cortical
thinning/breakthrough [46,47]. MRI was performed to
determine the diagnosis as well as to detect changing of
the adjacent soft tissues and bones [45-47,51]. The
mass showed low signal intensity on T1-weighted im-
ages, and then T2-weighted images presented high
signal intensity. Contrast-enhanced fat-suppressed T1-
weighted images demonstrated strong enhancement of
the lesion [48,51]. Tc-99m bone scintigraphy only showed
an uptake in the affected patella [45,46]. The CT scan of
the chest was necessary for identifying pulmonary meta-
static nodules [48].
Only in one case, ESR and white blood cell (WBC)
count were increased [49].
Photomicrograph of histology revealed the diffuse
proliferation of malignant cells that led to abundant
osteoid formation. The cells were spindle shaped, atypical
with large, hyperchromatic nuclei and prominent nucleoli
[46-50]. Irregular osteoid formation, pleomorphic malig-
nant fibrous histiocytoma-like areas, and telangiectatic
areas were also found in some special cases [46].
Surgery is still the main therapeutic approach. For
patellar OS, surgical methods, including patellectomy
(Enneking stage IIB, III) [45,50], wide resection (Ennek-
ing stage IIA) [46], amputation (Enneking stage IIB, III)[47,49], arthrodesis with an allograft and total joint re-
placement (Enneking stage III) [48], were performed in
patellar OS cases. Before and after surgery, all of the
patients experienced chemotherapy. The surgeon tried
the above-knee amputation, due to the poor results of
preoperative chemotherapy or previous surgery [47,49].
The excision was performed with safe surgical margins,
including for patella, the quadriceps tendon, a patella
tendon, intrapatellar fat pad, and a medial and lateral
retinacula [45,46]. Cho [45] reported that an allograft
patella was used for restoration of extensor mechanism
function which was a difficulty after wide resection. Arti-
ficial knee joint tumor prosthesis replacement was used
in one case because of the lesion spreading to the prox-
imal tibia and adjacent soft tissue [48]. Most of the cases
had no recurrence or metastasis on the patella within
short postoperative period [45,46,48]. Two patients pre-
sented metastatic disease [47,49].
Chondrosarcoma
Originating from cartilage tissues, chondrosarcoma (CS)
is the second most common primary bone tumor. It
may occur at any endochondral ossification of the whole
body bones, especially at the pelvis, femurs, humeruses,
and scapulas [52]. CS occurrence in the patella is still
scarce, with few cases being reported [33,53-55].
Clinically, increased mass, pain, swelling, and lameness
of the affected knee might be the main complaint of the
patellar CS patients [53,54]. The history of rheumatoid
arthritis or a history of struck injury on the knee maybe
caused patellar CS [53,54]. Upon examination, the patient
might have swelling and tenderness over the affected pa-
tella [55]. Mass on the patella could be touched and felt
[54]. The passive range of knee motion was limited in two
cases [53,54].
Radiographs of the affected knee joint showed a lytic
lesion shadow on the patella [53-55]. The tumor had a
well-defined sclerotic rim and indicated some cortical
continuity [54]. Meanwhile, the fracture shadow on the
patella could be found by X-ray [55]. Sometimes, CS could
mimic GCT with a ‘soap-bubble’ presentation and a
‘trumpet-shaped’ extension of the cortex [54]. MRI of the
tumor showed a comparatively clear boundary around the
lesion. T1-weighted images demonstrated low intensity,
while heterogeneous low-high combined intensities were
found on T2-weighted imaging with fat suppression [53].
Bone scan showed an increased focal activity on the lesion
of the affected patella [53]. Chest X-ray or CT should be
performed to determine lung metastasis.
Hematological tests of one case [53], including WBC
count and AP, were within the normal range. Rheuma-
toid factors and CRP levels were slightly increased in
one case, due to the history of rheumatoid arthritis. In
another case, only the increased ESR was found [55].
Table 1 Characteristic of other reviewed primary patellar tumors
Type Symptoms History Clinical
examination
Imaging Laboratory test Pathology Treatment
Lipoma [44] - - - R: a well-defined multilobulated
lytic lesion replacing part of the
patella
- The specimen demonstrated
a lobulated lesion
-
Ganglion [1,20,63] Immediate pain











R: a well-defined lytic lesion, a
pathological fracture, joint effusion,
lobulated margins, septa, sclerotic
rim, thick trabeculae. BS: a focal
solitary area of intense activity in
the affected patella
- A cyst-like lesion containing
fibromyxoid and ‘fatty’-












- A history of
thyroid-related
problems
- R: osteitis fibrosa cystica with
multiple irregular cystic areas
- - Excision of the lesion
(stage 1)














R: a mixed lytic and sclerotic lesion
with ill-defined margin in the
patella. CT: sclerotic rim and
osteolytic lesion with cortical
disruption. MRI: extraosseous high
signal intensity infiltration on
T2-weighted imaging. BS: isolated






Fascicles of centrally spindle











Angiosarcoma [1,20] - - - R: multicentric lesion, permeative
bone with cortex destruction and
ill-defined margins, joint involvement.
CT: destroyed cortex and






- - - R: a lobular contour with ill-defined
margins, septation ‘soap-bubble
appearance’, thinned and piercing
cortex, mimicking giant cell tumor
- - Patellectomy (stage IB),
radiotherapy (stage IA),
patellectomy and
radiotherapy (stage IA, IB)
CT: determination of radiographic
findings and indication of multiple
lesions. BS: Single increased activity
in the affected patella.
















R: mass-like change, sclerosis,
permeative change. MRI: marrow
replacement by tumor in the
patella, soft tissue mass, lesion
of proximal tibial, widespread
involvement of bone marrow in
the vertebral bodies and sacrum








Extensive necrosis of the
lesion, neoplasm composed




CD99 (+), nuclear FLI-1 (+)
Chemotherapy (stage IIIB)













Figure 5 Osteosarcoma of the patella. (A) Plain radiograph and (B, C) CT images reveal a lytic lesion in the patella with partial cortical disruption.
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by the lesion, and certain necrosis of its surrounding
bones and soft tissues could be found [53,54]. The lesion
consisted of fragments of gelatinous tissue and bony
spicules [54]. Yellow jelly-like material was drained from
the joint in some case [55]. Upon microscopic examin-
ation, trabecular bone was admixed with proliferating
chondroid tissue. Whereas, the arrangement of the cells
and their relation to the intercellular substance resem-
bled the structure of embryonal cartilage [54]. At higher
magnification, a small number of cells with two nuclei
and some single-nucleus cells with larger or smaller than
average-sized nuclei were found [53].
Adjuvant chemotherapeutic drugs or radiotherapy is
useless to CS due to its poor blood supply and lymph
circulation. The wide surgical resection is still regarded
as a mainstay method for treating CS [52]. The surgeons
performed excision plus partial patellectomy or amputa-
tion to eliminate the tumor (Enneking stage IB), while
amputation was also used for the worse case (EnnekingFigure 6 Patellar lymphoma with a pathologic fracture. (A) On radiograph
portion. (B) Permeative bone destruction, hazy margins, destroyed cortex, l
are shown on CT images.stage IIIB) [53-55]. The two patients who accepted post-
operative follow-up were found to have no recurrence in
several years [53,55].
Primary osseous lymphoma
Generally, lymphomas arise in lymph nodes, while their
formation in extranodal sites is less common. The patel-
lar POL accounts for approximately 4% of all the patellar
tumors.
One patient with the patellar POL presented pain, due
to a pathologic fracture [56]. A physical examination of
the affected knee could reveal swelling, painful flexion-
extension motion, active arthritis, and tender subcutane-
ous nodules [56,57].
The patella exhibited moth-eaten appearance and mul-
tiple lytic lesions on knee through X-ray inspection
[44,56,57]. A shadow of the fracture was shown as well
(Figure 6). Bone scans and imaging of the chest, abdo-
men, and pelvis failed to indicate any other involvement
[56,57].s, the patella consists of a sclerotic proximal portion and a lytic distal
arge soft tissue mass surrounding the patella, and joint involvement
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opsy, and synovial fluid were unremarkable [56,57].
Excised lesion revealed the diffuse infiltration of tumor
and/or surrounding tissues [44,57]. In the case of T-cell
lymphoma, differently sized lymphoid cells with less cy-
toplasm, vesicular nuclei, single or double conspicuous
nucleoli, and mitotic figures were found through the mi-
croscope. The cells could strongly stain CD3 and CD45
but not CD19 or CD30 [57]. Large B-cell lymphocytes
were positive to CD45 and CD20, having intermediate
proliferative activity; they were chased in the case of B-cell
lymphoma [56].
The common treatments for primary bone lymphoma
included the following: a combination of chemotherapy
and radiotherapy, chemotherapy alone, and radiotherapy
alone [58]. The POL patients (Enneking stage IIB) were
treated with cyclophosphamide, doxorubicin, vincristine,
and prednisone (CHOP) chemotherapy. But for the pa-
tients who suffered from severe POL (Enneking stage III)
had received radiotherapy following CHOP chemotherapy
[56,57]. Surgery was performed to repair the pathologic
fracture [56]. Finally, both of them recovered from the
disease. Only one recurrent case (Enneking stage III) was
found. That patient treated with radiotherapy died 1 year
later [1].
Malignant fibrous histiocytoma
Malignant fibrous histiocytoma (MFH), which arises in
both the soft tissues and the bones, is the most frequent
sarcoma of malignant soft tissue that is characterized by
aggressive biological behavior. Patellar MFH, which orig-
inates in some unusual location, accounts for 1% of all
the patellar tumors [1].
The patient’s complaints include pain, swelling, de-
creased range of motion, anorexia, and weight loss
[59,60]. Physical examination could show swelling, ten-
derness, cutaneous erythema, and restricted knee motion
[60]. One of the cases had a knife wound before his admis-
sion [60].Figure 7 Patellar leiomyosarcoma. (A) Plain radiograph shows a mixed lyti
and associated with cortical breach. (B) CT scan reveals multiple lytic lesionThe radiographs showed multiple radiolucent lesion
and permeating destruction in the patella [59,60]. Sep-
tated lesion and sclerosing areas were also found [60].
Plain films of knee joint could detect a fracture line [60].
CT scans demonstrated a mass and involvement of sur-
rounding tissue. Bone scans were used to determine me-
tastasis and other imaging results.
The only abnormal laboratory finding was the increased
level of ESR [59,60]. The knee fluid test demonstrated 1+
WBC in one case [60].
Generally, specimen showed grayish, whorled tissue
with thin, calcified septa and thinned cortex [60]. There
were nodules which consisted of polymorphic cells with
large eosinophilic cytoplasms that were epithelioid-like
in appearance [60]. MFH cells possessed prominent nu-
clear pleomorphism, hyperchromasia, and nuclei irregu-
larity [59,60]. In some other areas, fusiform cells with a
marked storiform pattern were found. Nontumoral bone
trabeculae within the neoplasm were present, some lack-
ing osteocytes. A positive intracellular stain with acid
phosphatase was detected by histochemical method. The
electron microscopy proved fusiform and polygonal
structure of cellular elements [60].
The treatments of osseous MFH included wide re-
section, additional radiotherapy, adjuvant chemotherapy,
systemic treatment approach, or the combination [61].
The first patellar MFH case (Enneking stage III) was re-
ported to have undergone curative resection plus pros-
thesis but eventually died of the disease [50]. Amputation
plus prosthesis fitting followed by chemotherapy had been
employed to treat another patellar MFH patient (Enneking
stage IIB). And no recurrence was found within 18 months
after the treatment [59].
Other malignant patellar tumor
Other sporadic malignant cases that were ever reported,
such as leiomyosarcoma (Figure 7), angiosarcoma, he-
mangioendothelioma (Figure 8), and Ewing’s sarcoma,
have been summarized in the Table 1.c and sclerotic lesion of patella. The margin of the lesion is ill defined
s of the patella with a sclerotic rim and cortical disruption.
Figure 8 Hemangioendothelioma of the patella. Septation and thinning cortex in the osteolytic lesion are observed on (A) plain radiographs and
(B) CT images.
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The patella is defined as a sesamoid originating in the
quadriceps tendon. It develops from a cartilaginous pre-
cursor in the third month of gestation and ossifies about
3 years of age [1]. Its ossification is similar to that of a
long bone’s epiphysis or apophysis. This makes the pa-
tella a possible location of bony lesions [62]. Due to lim-
ited published literatures, we still know a little about
patellar neoplasms. As the patellar neoplasms are such a
rare etiology as anterior knee pain, their determination
is often postponed. However, a majority of primary pa-
tellar neoplasms usually cause a dilemma in diagnosis.
Therefore, physicians urgently need more evidences to
distinguish primary patellar tumors from other kind of
lesions through integrated analysis of epidemiology,
pathogenesis, symptomatology, imageology, and histo-
pathology and in reference to the reported treatments.
The most common symptom of primary patellar tu-
mors is knee pain that usually lasts a long period of time
from pain onset to determination upon diagnosis [50].
For benign tumors, the feeling of pain is gaining slowly;
for malignant ones, the feeling of pain enhances more
rapidly. Sometimes, the immediate pain will present after
injury history, resulting from a pathological fracture.
Swelling - the secondary common complaint - occurs in
several cases of both benign and malignant tumors.
Upon physical examination, the impaired function of
flexion and extension is easier to be determined than the
patient’s complaint is. Affected by pain and swelling, the
motion range of the diseased knee is forced to decrease.
With the limitation of motion and limp, patients may
find muscle atrophy of the quadriceps. Mass is another
main complaint which is often indicated through the
process of palpation. Noticeably, primary malignancies
and aggressive tumors of the patella can raise local red-
ness, heat, effusion, and other inflammatory representa-
tions. When signs of weight loss, night sweats, and other
cachexia occur, physicians should mark a red flag for thepossible malignant tumors. Moreover, there may be a re-
lationship between the lesion site and the tumor type.
In patients with anterior knee pain, plain radiograph
is the most common way to find patellar anomalous
changes and can accelerate the diagnosis of a patellar
tumor [50]. In most cases, radiographs of the patellar
tumor accord with those of large bones. However, depend-
ing on the peculiarity of dimension, shape, and structure,
radiographic reports of patellar tumors are still distinctive
from one to another. More considerations should be made
to imaging changes, such as bone destruction, extent,
margins, cortex, sclerotic rim, septation, calcifications,
ossification, periosteal reaction, pathologic fracture, and
surrounding involvement. For benign tumors, ‘geographic
aspect’ osteolytic lesion with well-defined margins and
sclerotic rims are typical characteristics. Ossification, cal-
cifications, and pathologic fracture are normal, as well
(Table 2). Malignant and aggressive benign tumors are
frequently accompanied by permeative destruction, total
patellar extension, ill-defined margins, ossifications, and
pathologic fracture (Table 2). Remarkably, involvement of
surroundings is of utmost importance to the knee X-ray
as well as to a visual measure to differentiate the malig-
nant from the benign. Nevertheless, radiographic diagno-
sis is not absolutely correct because metastasis cancer,
plasmacytoma, Paget’s disease, osteomyelitis, hyperpara-
thyroidism, gout, and tuberculosis often mimic lytic neo-
plastic lesions of the patella [1]. Primary patellar tumors
are often not studied through imaging results, which are
otherwise very helpful to determining the staging of the
lesion and the appropriate surgical course. Radiographic
results combined with those of the CT and MRI are often
needed to determine former diagnosis, surrounding in-
volvement, and precise presentation of the tumor site.
With bone scan, part of the primary patellar tumors is
indicated as having only increased focal activity on the
lesion of the affected patella. Among the existing case
reports, the difficulty to obtain different diagnoses based
Table 2 Typical radiographic features of benign and malignant patellar tumors
Presentation Benign patellar tumors Malignant patellar tumors
Bone destruction Geographic aspect Permeative or moth-eaten aspect
Extent Eccentric area or total patella Eccentric area or total patella
Margins Lobulated or sharp or rounded verge Ill-defined verge
Cortex Thinned or expanded or thinned and expanded change Permeative or destroyed change
Periosteal shell - Rare
Sclerotic rim Common -
Periosteal reaction - Rare
Septation Common Common
Calcifications Rare -
Reactive bone Rare Rare
Pathologic fracture Rare Common
Invasion of surrounding tissue and joint involvement Rare Common
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existence of CB and ABC, CS-mimicking GCT, and
OS-mimicking GCT are the problems that should be
resolved by analyzing the results of histological examin-
ation. In addition, chest radiograph or CT is recommended
for all the patients with primary patellar tumors, especially
with malignant ones.
The past reviews on the topic of patellar tumors are
short of supports by laboratory tests, due to the insuffi-
cient reports and unusual changes. But as relative cases
are increasing, a certain amount of data has been made
available. Although the routine laboratory tests are usu-
ally within the normal ranges, a pathological fracture
may lead to the increased levels of serum calcium and
AP. A rise in levels of WBC and ESR can be detected in
some malignant cases after laboratory tests. This may
pertain to the secondary inflammatory reaction. Synovial
fluid examination has been used, which is of certain sig-
nificance to some cases. Therefore, laboratory tests must
not be overlooked.
Radiographic features of primary patellar tumors are
atypical of a specific histotype. Histological examination
is preferred, but in view of the risk of contamination, a
needle biopsy is a better option. An incisional biopsy is
recommended if the diagnosis and the radiographic fea-
tures are paradoxical. Two key points should be noticed:
(1) In needle biopsy, the joint must not be entered; (2)
in incisional biopsy, the patellar and quadriceps tendon,
the joint cavity, and the synovial membrane must not be
contaminated [1]. Histological examination is still a ‘gold
standard’ to determine the specific type of tumors, espe-
cially of the malignant ones. To our delight, pathological
features will not change as the site of the tumor changes.
Different types of patellar tumors still exhibit their in-
trinsic pathological characteristics. For instance, typical
spindle-shaped cells with large, hyperchromatic nucleiand prominent nucleoli were found in the biopsied tissue
of the patellar OS [47-49].
Surgery is the most effective treatment for most of the
symptomatic patients who have a patellar tumor. Sur-
geons prefer to outline a course of treatment according
to Enneking stages [1]. Some advices are provided as fol-
lows: (1) Stage 1 tumors: only curettage with or without
grafts or excision of the lesion is recommended. (2)
Stage 2 tumors: curettage with adjuvants and grafting
are a better option. (3) Stage 3 tumors: total patellect-
omy is widely used. (4) Stage IA tumors: total patellect-
omy or wide excision can keep the affected knee in good
function. (5) Stage IB tumors: a patellectomy and wide
excision of the tendons and skin concerned is made
available. (6) Stage IIA tumors: resection with a wide
margin is recommended. Total patellectomy with re-
moval of the distal part of the quadriceps tendon, of the
proximal part of the patellar tendon and of the over
patellar fascia, is necessary. (7) Stage IIB tumors: in the
case with minimal invasion of adjacent soft tissue, a wide
resection and adequate reconstruction is preferred. Am-
putation is performed in the case with severe involve-
ment of surrounding soft tissue. (7) Stage 1 or stage 2
tumors: a pathologic fracture can be healed by conser-
vative treatment. (8) Stage 3 or stage IA tumors with a
pathologic fracture and involvement of synovium: a syno-
vectomy or a knee resection is recommended. (9) Stage IB
or stage IIA tumors with a pathologic fracture: a total
patellectomy with wide margins is preferred. (10) Stage
IIB tumors: a pathologic fracture does not change treat-
ment indications. For stage III tumors, the appropriate
surgical intervention combined with radiotherapy or/and
chemotherapy are rational because of regional invasion or
metastases. Moreover, according to different characteri-
zation of patients, suitable surgical options may range from
simple curettage with bone grafting, excision, patellectomy,
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to above-knee amputation. If curettage is performed, pre-
vention of tumor spread in the joint should be considered.
If the external shell of reactive bone cannot be kept
according to preoperative radiographic results, a patellect-
omy is better than a curettage. In order to preserve mo-
tional function, surgeons should keep intact the extensor
apparatus or reconstruct extensor structure. Neoadjuvant
chemotherapy has been used as a potential treatment for
some primary malignant tumors. Radiotherapy should be
chosen to treat highly radiosensitive tumors and benign
tumors after incomplete excision. For certain postopera-
tive tumors (stage 3), radiotherapy was unsuitable because
of radiation-induced malignant degeneration [6]. Now,
radiotherapy was only used for multiple malignant lesions,
especially hematologic and vascular malignancies [1,20].
Conclusions
Although anterior knee pain seems simple, the primary
tumors originating in the patella as a possible lesion can-
not be neglected. More types of unreported primary pa-
tellar tumors will be confirmed. Due to the insufficient
availability of the patellar characteristics, the integrated
diagnosis of primary patellar tumors should be seriously
considered. The extended application of MRI and CT is
necessary. And noninvasive biopsy is worth studying in
order to avoid contamination. While experts are inclined
to outline a course of treatment for primary patellar tu-
mors according to Enneking stages, new adjuvant therapy
and improved methods of functional reconstruction may
do more good to the patients.
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